Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2/3 × Cardiovascular Diseases × Fatty Acids, Omega-3 × Clear all

Phase

Phase 3 1 Phase 2/3 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Neoplasms 1 Hypertension 1 Diabetes Mellitus 1 Depressive Disorder, Major 1 Depression 1 Cardiovascular Diseases 1

Interventions

Fatty Acids, Omega-3 1 Desvenlafaxine Succinate 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01803711 2017-12-27

Omega 3 FA Supplements as Augmentation in the Treatment of Depression

UConn Health

Phase 2/3 Terminated

6 enrolled 4 charts

Cardiovascular Diseases, Depression, Depressive Disorder, Major, Diabetes Mellitus, Hypertension, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡